Cargando…

Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy

Immunotherapy has greatly improved the outcomes of patients with metastatic melanoma. However, it has also led to new patterns of response and progression, creating an unmet need for better biomarkers to identify patients likely to achieve a lasting clinical benefit or experience immune-related adve...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGale, Jeremy, Hama, Jakob, Yeh, Randy, Vercellino, Laetitia, Sun, Roger, Lopci, Egesta, Ammari, Samy, Dercle, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573034/ https://www.ncbi.nlm.nih.gov/pubmed/37835808 http://dx.doi.org/10.3390/diagnostics13193065

Ejemplares similares

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy
por: Dercle, Laurent, et al.
Publicado: (2022)

Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma
por: Higgins, Hayley, et al.
Publicado: (2023)

Investigating of the role of CT scan for cancer patients during the first wave of COVID-19 pandemic
por: Bourdoncle, Sylvain, et al.
Publicado: (2022)

Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [(18)F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Lopci, Egesta
Publicado: (2021)

More than Just Skin-Deep: A Review of Imaging’s Role in Guiding CAR T-Cell Therapy for Advanced Melanoma
por: Prendergast, Conor M., et al.
Publicado: (2023)

Meditating on Cancer Management at the Time of Immunotherapy
por: Lopci, Egesta
Publicado: (2022)

Integrating [(18)F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors
por: Prendergast, Conor M., et al.
Publicado: (2023)

The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria
por: Castello, Angelo, et al.
Publicado: (2022)

Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022)

Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan
por: Viansone, Alessandro A., et al.
Publicado: (2021)

Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence
por: Sinigaglia, Mathieu, et al.
Publicado: (2019)

Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology
por: Shaw, Ashley, et al.
Publicado: (2022)

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence
por: Dercle, Laurent, et al.
Publicado: (2017)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

Artificial intelligence and radiomics for radiation oncology
por: Kocher, Martin
Publicado: (2020)

Advances in Lung Cancer Imaging and Therapy
por: Lopci, Egesta, et al.
Publicado: (2021)

Editorial: Response assessment of radioligand therapies
por: Lopci, Egesta, et al.
Publicado: (2022)

Radiomics and artificial intelligence in lung cancer screening
por: Binczyk, Franciszek, et al.
Publicado: (2021)

The application of artificial intelligence and radiomics in lung cancer
por: Zhou, Yaojie, et al.
Publicado: (2020)

Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence
por: Kim, Nari, et al.
Publicado: (2022)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence
por: Partouche, Ephraïm, et al.
Publicado: (2021)

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab
por: Ammari, Samy, et al.
Publicado: (2021)

Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy
por: Vercellino, Laetitia, et al.
Publicado: (2021)

18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
por: Castello, Angelo, et al.
Publicado: (2020)

Radiomics with artificial intelligence for precision medicine in radiation therapy
por: Arimura, Hidetaka, et al.
Publicado: (2019)

State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
por: Castaldo, Anna, et al.
Publicado: (2021)

Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology
por: Galldiks, Norbert, et al.
Publicado: (2021)

Editorial: The Application of Radiomics and Artificial Intelligence in Cancer Imaging
por: Huang, Hong
Publicado: (2022)

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology
por: Kang, Cyra Y, et al.
Publicado: (2022)

Editorial: Radiomics and artificial intelligence in radiology and nuclear medicine
por: Annunziata, Salvatore, et al.
Publicado: (2023)

Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an In Vitro and In Vivo Study
por: Ammari, Samy, et al.
Publicado: (2021)

Toward radiomics for assessment of response to systemic therapies in lung cancer
por: Sun, Shawn, et al.
Publicado: (2020)

Radiomics and Artificial Intelligence for Biomarker and Prediction Model Development in Oncology
por: Forghani, Reza, et al.
Publicado: (2019)

Radiomics based on artificial intelligence in liver diseases: where are we?
por: Hu, Wenmo, et al.
Publicado: (2020)

Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging
por: Abdel Razek, Ahmed Abdel Khalek, et al.
Publicado: (2021)

Radiomics and Artificial Intelligence in Uterine Sarcomas: A Systematic Review
por: Ravegnini, Gloria, et al.
Publicado: (2021)

Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
por: Assi, Tarek, et al.
Publicado: (2020)

Applying artificial intelligence for cancer immunotherapy
por: Xu, Zhijie, et al.
Publicado: (2021)

Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1
por: Castello, Angelo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n5li03mselkfkgtndjmccd2i4f